UniQuest start-up company Dendright Pty Ltd today announced that US-based Janssen Biotech, Inc.
Patients at risk of life-threatening infections following chemotherapy could benefit from a new cell-based treatment developed from University of Queensland research.
Friendly bacteria may be introduced to bagged salad leaves to help ward off the possibility of salmonella and listeria outbreaks.
Two companies founded on University of Queensland research have won acclaim at the National AusBiotech Conference in Melbourne.
UniQuest has congratulated Redback Technologies following the company’s announcement that it had secured A$9.3 million in Series A funding.
A treatment developed at The University of Queensland to control sewer odour and corrosion is set for the international market.
Three projects selected to receive funding under an “open innovation” program could lead to new treatments for some cancers.
Inflazome Ltd has closed a Series A financing round of €15 million (A$22 million).
Pfizer’s Centers for Therapeutic Innovation is a unique program that aims to speed the translation of novel targets to the clinic.
UniQuest congratulates Protagonist Therapeutics Inc on the news that the biotech company has raised $ US90 million in its initial public offering.
UniQuest congratulates ResApp Health Limited following the company’s announcement that it is planning a clinical study at Massachusetts General Hospital.
UQ has become the first Australian institution to join an exclusive international organisation focused on driving partnerships between universities and industry.
University of Queensland pain drug pioneer Professor Maree Smithhas joined an elite group of scientists tonight, receiving the prestigious ATSE Clunies Ross Award.
Queensland researchers have made a big leap forward in their quest to eradicate the billions of cane toads wreaking havoc on our native wildlife and habitats.
Patients with heart failure, peripheral artery disease or stroke could benefit from a new stem-cell based treatment, following an agreement with US-based AngioStem Inc.
UniQuest Pty Ltd
Level 7, General Purpose South Building (Building 78)
Staff House Road
The University of Queensland
Brisbane, Queensland 4072
+61(0)7 3365 4037
The main commercialisation company of
© Copyright 2014 UniQuest
ABN 19 010 529 898